Bioharvest Sciences Inc
OTC:CNVCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (6.7), the stock would be worth $-1.99 (139% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -17.2 | $5.13 |
0%
|
| Industry Average | 6.7 | $-1.99 |
-139%
|
| Country Average | 11.9 | $-3.57 |
-170%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
B
|
Bioharvest Sciences Inc
OTC:CNVCF
|
160.4m USD | -17.2 | -6.8 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
303.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 45 425.5 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.5B ZAR | 18.1 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68B USD | -45 946.1 | 38 417.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
61.5B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.4B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
38.1B USD | 42.2 | -3 481.5 | |
| US |
|
Coupang Inc
F:788
|
31.7B EUR | 17.9 | 175.5 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.4B USD | 40.1 | 57 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 11.9 |
| 70th Percentile | 19.5 |
| Max | 22 577.3 |
Other Multiples
Bioharvest Sciences Inc
Glance View
BioHarvest Sciences, Inc. develops bio farming technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The firm is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The firm is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).
